Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial.

Helft G, Steg PG, Le Feuvre C, Georges JL, Carrie D, Dreyfus X, Furber A, Leclercq F, Eltchaninoff H, Falquier JF, Henry P, Cattan S, Sebagh L, Michel PL, Tuambilangana A, Hammoudi N, Boccara F, Cayla G, Douard H, Diallo A, Berman E, Komajda M, Metzger JP, Vicaut E; OPTImal DUAL Antiplatelet Therapy Trial Investigators.

Eur Heart J. 2016 Jan 21;37(4):365-74. doi: 10.1093/eurheartj/ehv481. Epub 2015 Sep 12.

PMID:
26364288
2.

Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.

Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J, Defaye P, Jacob S, Piot O, Deharo JC, Perier MC, Mulak G, Hermida JS, Milliez P, Gras D, Cesari O, Hidden-Lucet F, Anselme F, Chevalier P, Maury P, Sadoul N, Bordachar P, Cazeau S, Chauvin M, Empana JP, Jouven X, Daubert JC, Le Heuzey JY; CeRtiTuDe Investigators.

Eur Heart J. 2015 Nov 1;36(41):2767-76. doi: 10.1093/eurheartj/ehv455. Epub 2015 Sep 1.

3.

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.

4.

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators.

PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.

5.

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY Investigators.

PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3.

6.

Characteristics and management of outpatients with history of or current atrial fibrillation: the observational French EPHA study.

Cohen A, Dallongeville J, Durand-Zaleski I, Bouée S, Le Heuzey JY; EPHA Investigators.

Arch Cardiovasc Dis. 2010 Jun-Jul;103(6-7):376-87. doi: 10.1016/j.acvd.2010.06.001. Epub 2010 Jul 22.

7.

[Paradoxical embolism and thrombosis trapped in the foramen ovale. Role of transesophageal echocardiography].

Augusseau MP, Pacouret G, Charbonnier B, Sirinelli A, Dreyfus X, Aupart M.

Arch Mal Coeur Vaiss. 1997 Nov;90(11):1533-8. French.

PMID:
9539828
8.

The last generation of pericardial valves in the aortic position: ten-year follow-up in 589 patients.

Aupart MR, Sirinelli AL, Diemont FF, Meurisse YA, Dreyfus XB, Marchand MA.

Ann Thorac Surg. 1996 Feb;61(2):615-20.

PMID:
8572776
9.

[Aortic valve replacement with pericardial bioprosthesis in patients under 60 years of age. Experience over 10 years].

Aupart M, Hammami S, Sirinelli A, Dreyfus X, Meurisse Y, Marchand M.

Ann Chir. 1996;50(5):367-73. French.

PMID:
8761106
10.

[Transesophageal echography and systemic ischemic incidences: 235 cases].

Paemelaère JM, Sirinelli A, Dreyfus X, Maillard L, Pottier JM, Raynaud P.

Rev Neurol (Paris). 1996 Jan;152(1):27-31. French.

PMID:
8729393
11.

The influence of age on valve related events with Carpentier-Edwards pericardial valves.

Aupart MR, Dreyfus XB, Meurisse YA, Rouchet SC, Sirinelli AL, May MD, Marchand MA.

J Cardiovasc Surg (Torino). 1995 Aug;36(4):297-302.

PMID:
7593137
12.

[Influence of the valve position on the complications related to pericardial Carpentier-Edwards valve after 8 years].

Aupart M, Dreyfus X, Meurisse Y, May MA, Sirinelli A, Marchand M.

Arch Mal Coeur Vaiss. 1995 Jul;88(7):967-71. French.

PMID:
7487327
13.

[Surgery of valve replacement with pericardial prosthesis].

Aupart M, Meurisse Y, Dreyfus X, Sirinelli A, Neville P, Rouchet S, Marchand M.

Presse Med. 1995 Apr 1;24(13):647-50. Review. French.

PMID:
7761366
14.

New procedure to replace the aortic valve with autologous pericardium: a clinical case.

Aupart M, Meurisse Y, Dreyfus X, Diemont F, Sirinelli A, Marchand M.

Ann Thorac Surg. 1994 Jul;58(1):245-7.

PMID:
8037539
15.

The Carpentier-Edwards pericardial aortic valve: intermediate results in 420 patients.

Aupart M, Neville P, Dreyfus X, Meurisse Y, Sirinelli A, Marchand M.

Eur J Cardiothorac Surg. 1994;8(5):277-80.

PMID:
8043292
16.

[Complete cusp rupture of Hancock pericardial bioprosthesis with systemic embolism. Apropos of a case].

Meurisse Y, Dreyfus X, Aupart M, Tabet A, Neel G, May MA, Marchand M.

Arch Mal Coeur Vaiss. 1993 Nov;86(11):1629-31. French.

PMID:
8010863
17.

[Angioplasty after failure of thrombolysis in myocardial infarction. Hospital results apropos of 40 consecutive patients].

Rioux P, Dreyfus X, Desveaux B, Quilliet L, Pacouret G, Maillard L, Charbonnier B, Raynaud P, Brochier M.

Ann Cardiol Angeiol (Paris). 1992 Jan;41(1):1-6. Review. French.

PMID:
1558360
18.

Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis.

Gruel Y, Lang M, Darnige L, Pacouret G, Dreyfus X, Leroy J, Charbonnier B.

Lancet. 1990 Oct 27;336(8722):1077-8. No abstract available.

PMID:
1977060

Supplemental Content

Loading ...
Support Center